Promising research published on the susceptibility to and drug targets for Parkinson's disease

GRONINGEN, The Netherlands—On average, the population of the western world is living longer, resulting in an increased number of people with age-related neurological conditions. Parkinson’s disease is the second most common brain disorder of the elderly. It is thought to be caused by environmental and genetic factors.
| 2 min read
To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Related Topics

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

: A magnifying glass focuses on a puzzle piece labeled “mRNA,” symbolizing examining or analyzing messenger RNA.
A streamlined analytical strategy supports reliable plasmid and mRNA quality assessment at every mRNA production stage.
A 3D illustration of two glowing cells with visible nuclei floating in a purple and blue gradient background.
Explore evolving technologies, analytical strategies, and expert guidance supporting high-quality flow cytometry research.
Bands of diffused color illustrating pigment separation.
Discover how supercritical fluids expand chromatographic capabilities across diverse analytical challenges.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue